Elizabeth Anne Wright

Partner
Full contact info

I help clients navigate the European Union’s life sciences regulations to successfully introduce and retain their often lifesaving or life-sustaining products on the EU market.

Experience

Alto Neuroscience Announces $147.9 Million IPO

February 6, 2024

Cooley advised Alto Neuroscience, a company redefining psychiatry by leveraging individuals’ neurobiology to develop personalized and highly effective medicines and helping patients get better faster, on its $147.9 million initial public offering.

Read more

Related contacts

Div Gupta
Partner, New York
Christina T. Roupas
Partner in Charge – Chicago, Chicago
Courtney M.W. Tygesson
Partner, Chicago
Laurie Bauer
Partner, Chicago
Nyron J. Persaud
Partner, New York
Kate Hillier
Partner, Seattle
Jon Cousin
Partner, Washington, DC
Elizabeth Anne Wright
Partner, Brussels
Eileen Marshall
Partner, Washington, DC
Geoffrey Spolyar
Partner, Boston
Stephanie Gentile
Partner, New York
Steve Flores
Partner, Chicago
Peter Adams
Partner, San Diego
Phil Mitchell
Partner, New York
Courtney Thorne
Partner, Boston
David Navetta
Partner, Colorado
Francis Wheeler
Partner, Colorado
Natasha Leskovsek
Of Counsel, Washington, DC
Jennifer Shanley
Special Counsel, New York
Rebecca Ross
Special Counsel, Washington, DC
Randy Sabett
Special Counsel, Washington, DC
Dani Nazemian
Special Counsel, San Diego
Katie Lapidus
Associate, Washington, DC
Trey Reilly
Associate, New York
Adam Bloom
Associate, Chicago
David D. Suh
Associate, Palo Alto
Dionne A. Thomas
Associate, San Diego
Megan E. Bowles
Associate, Chicago
Mor Agam
Associate, New York
Nat Sherrick
Associate, Washington, DC
Edmond Lay
Associate, San Diego
Addison Pierce
Associate, Chicago
Calvin Lee
Associate, New York
Andrew Nelms
Associate, San Francisco
Jason Minio
Paralegal Specialist, Boston
Jeffery Wyzykowski
Patent Agent, Washington, DC

Related Practices & Industries

Allorion Therapeutics Announces Exclusive Option, Global License Agreement With AstraZeneca

January 2, 2024

Cooley advised Allorion Therapeutics, a US- and China-based biotechnology company that focuses on the discovery of new small molecule drugs for treating cancer and autoimmune diseases, on its exclusive option and global license agreement with AstraZeneca to develop and commercialize a novel epidermal growth factor receptor (EGFR) L858R mutated allosteric inhibitor as a potential new treatment for advanced EGFR-mutant non-small-cell lung cancer.

Read more

Related contacts

Marya Postner
Partner, Palo Alto
Brendan Haberle
Associate, San Diego
Yiming Liu
Partner in Charge – Shanghai, Shanghai
Jameson Davis
Associate, Palo Alto
Xander Lee
Partner, Los Angeles Santa Monica
Mor Agam
Associate, New York
Sharon Connaughton
Special Counsel, Washington, DC
Rachel Thorn
Partner, New York
Elizabeth Anne Wright
Partner, Brussels
Natasha Leskovsek
Of Counsel, Washington, DC
Jessica Koffel
Associate, Brussels
Robert Eisenbach
Of Counsel, San Francisco

Related Practices & Industries

Abivax Announces $235.8 Million IPO

October 20, 2023

Cooley advised Abivax, a clinical-stage biotech company focused on developing therapeutics that harness the body’s natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases, on its $235.8 million initial public offering.

Read more

Related contacts

Div Gupta
Partner, New York
Marc Recht
Partner, Boston
Ryan Sansom
Partner, Boston
Denny Won
Partner, San Francisco
Aaron Pomeroy
Partner, Colorado
Richard Segal
Partner, New York
Nyron J. Persaud
Partner, New York
Madhuri Roy
Partner, Palo Alto
Courtney Thorne
Partner, Boston
Elizabeth Anne Wright
Partner, Brussels
Xander Lee
Partner, Los Angeles Santa Monica
Phil Mitchell
Partner, New York
Stephanie Gentile
Partner, New York
Kevin King
Partner, Washington, DC
Katie Kazem
Partner, Reston
Natasha Leskovsek
Of Counsel, Washington, DC
Rebecca Ross
Special Counsel, Washington, DC
Randy Sabett
Special Counsel, Washington, DC
Jennifer Shanley
Special Counsel, New York
Reid Hooper
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Minkyu Park
Associate, New York
Jesse Schulman
Associate, Washington, DC
Barry Kuang
Associate, Boston
Olivia Creser
Associate, New York
Peter A. Haddad
Associate, San Diego
Samuel Paullin
Associate, Chicago
Evan Leitner
Associate, New York
Rick Jantz
Associate, Los Angeles Santa Monica
Cara Buchicchio
Associate, New York
Jason Valentine
Associate, Washington, DC
Jessica Koffel
Associate, Brussels
Mor Agam
Associate, New York
Cathy Rude
Senior Paralegal, Boston

Related Practices & Industries

Turnstone Biologics Announces Upsized $80 Million IPO

July 26, 2023

Cooley advised Turnstone Biologics, a clinical-stage biotechnology company, on its upsized $80 million initial public offering.

Read more

Related contacts

Div Gupta
Partner, New York
Ryan Sansom
Partner, Boston
Lila Hope
Partner, Palo Alto
Valerie Sapozhnikova
Associate, Los Angeles Downtown
Julianne Orr
Associate, San Francisco
Anitha Anne
Associate, San Francisco
Cathy Rude
Senior Paralegal, Boston
Natasha Leskovsek
Of Counsel, Washington, DC
Phil Mitchell
Partner, New York
Alessandra Murata
Partner, Palo Alto
Tony P. Guan
Associate, Los Angeles Santa Monica
Elizabeth Anne Wright
Partner, Brussels
Jessica Koffel
Associate, Brussels
Aaron Pomeroy
Partner, Colorado
Rick Jantz
Associate, Los Angeles Santa Monica
Xander Lee
Partner, Los Angeles Santa Monica
Francis Wheeler
Partner, Colorado

Related Practices & Industries

Condor Secures Victory in Lufthansa’s COVID-19 State Bailout

May 15, 2023

Cooley advised Condor, a German leisure airline, in its victory against the approval of Lufthansa’s 2020 state bailout.

Read more

Related contacts

Alexander Israel
Partner in Charge – Brussels, Brussels
Elizabeth Anne Wright
Partner, Brussels
Jan Lang
Associate, Brussels
Georgina Dietrich
Associate, Brussels
David Burns
Special Counsel, Washington, DC

Related Practices & Industries

View more

Rankings & accolades

Chambers Europe 2017-2023, Life Sciences in Belgium, Band 1; Regulatory: Life Sciences/Pharma Europe-wide, Band 2

Legal 500 EMEA 2018-2023, EU Regulatory: Pharma, Medical Devices and Biotech, Leading Individual; EU Regulatory: Food

Who’s Who Legal 2021-2023, Life Sciences Regulatory; Recommended

Best Lawyers in Belgium 2020, Biotechnology and Life Sciences Practice

Elisabethann Wright has strong expertise that I have relied on for many years.

Chambers EU

I’ve worked with Elisabethann for years, and trust her judgement and ability to understand and weigh the business needs against the regulatory landscape.

Legal 500 EU